On the other hand, glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1 analogs), a class of medications used as therapeutic agents in T2DM, have shown cardioprotective effects against ceramide accumulation. This evidence concerns the gene GCG and type 2 diabetes mellitus.